These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21727969)

  • 1. Chemoenzymatic synthesis of biotin-appended analogues of gangliosides GM2, GM1, GD1a and GalNAc-GD1a for solid-phase applications and improved ELISA tests.
    Pukin AV; Florack DE; Brochu D; van Lagen B; Visser GM; Wennekes T; Gilbert M; Zuilhof H
    Org Biomol Chem; 2011 Aug; 9(16):5809-15. PubMed ID: 21727969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GM3, GM2 and GM1 mimics designed for biosensing: chemoenzymatic synthesis, target affinities and 900 MHz NMR analysis.
    Pukin AV; Weijers CA; van Lagen B; Wechselberger R; Sun B; Gilbert M; Karwaski MF; Florack DE; Jacobs BC; Tio-Gillen AP; van Belkum A; Endtz HP; Visser GM; Zuilhof H
    Carbohydr Res; 2008 Mar; 343(4):636-50. PubMed ID: 18255051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoenzymatic synthesis of 2-azidoethyl-ganglio-oligosaccharides GD3, GT3, GM2, GD2, GT2, GM1, and GD1a.
    Blixt O; Vasiliu D; Allin K; Jacobsen N; Warnock D; Razi N; Paulson JC; Bernatchez S; Gilbert M; Wakarchuk W
    Carbohydr Res; 2005 Sep; 340(12):1963-72. PubMed ID: 16005859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
    Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first total synthesis of ganglioside GalNAc-GD1a, a target molecule for autoantibodies in Guillain-Barré syndrome.
    Fujikawa K; Nakashima S; Konishi M; Fuse T; Komura N; Ando T; Ando H; Yuki N; Ishida H; Kiso M
    Chemistry; 2011 May; 17(20):5641-51. PubMed ID: 21469228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance.
    Hao Q; Saida T; Yoshino H; Kuroki S; Nukina M; Saida K
    Ann Neurol; 1999 Jun; 45(6):758-68. PubMed ID: 10360768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in bindings to the GM1 receptor by heat-labile enterotoxin of human and porcine Escherichia coli strains.
    Olsvik O; Lund A; Berdal BP; Bergan T
    NIPH Ann; 1983 Jun; 6(1):5-15. PubMed ID: 6353279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni enteritis].
    Tsuda N; Negoro K; Morimatsu M; Saito K; Yuki N
    Rinsho Shinkeigaku; 1995 Feb; 35(2):208-10. PubMed ID: 7781242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies.
    Lopate G; Choksi R; Pestronk A
    Muscle Nerve; 2002 Jun; 25(6):828-36. PubMed ID: 12115971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese hamster ovary cells lacking GM1 and GD1a synthesize gangliosides upon transfection with human GM2 synthase.
    Rosales Fritz VM; Daniotti JL; Maccioni HJ
    Biochim Biophys Acta; 1997 Nov; 1354(2):153-8. PubMed ID: 9396632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of high-affinity binding between gangliosides and amyloid beta-protein.
    Ariga T; Kobayashi K; Hasegawa A; Kiso M; Ishida H; Miyatake T
    Arch Biochem Biophys; 2001 Apr; 388(2):225-30. PubMed ID: 11368158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
    Nobile-Orazio E; Giannotta C; Briani C
    J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete chemoenzymatic synthesis of the Forssman antigen using novel glycosyltransferases identified in Campylobacter jejuni and Pasteurella multocida.
    Houliston RS; Bernatchez S; Karwaski MF; Mandrell RE; Jarrell HC; Wakarchuk WW; Gilbert M
    Glycobiology; 2009 Feb; 19(2):153-9. PubMed ID: 18955372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
    Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
    Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of sandwich-ELISA and GM1-ELISA for the detection of Escherichia coli thermolabile enterotoxin.
    Drevet P; Guinet R
    J Immunoassay; 1991; 12(3):293-304. PubMed ID: 1939662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural basis for the susceptibility of gangliosides to enzymatic degradation.
    Sonnino S; Brocca P; Acquotti D; Bernardi A; Raimondi L; Kiso M; Ishida H; Li SC; Li YT
    Biosci Rep; 1999 Jun; 19(3):163-8. PubMed ID: 10513893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of haemin on the enterotoxin production of Campylobacter jejuni.
    Suzuki S; Horikoshi Y; Takama K
    Microbios; 1997; 92(371):91-5. PubMed ID: 9589608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.